Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy

2015 ◽  
Vol 19 (11) ◽  
pp. 1143-1156 ◽  
Author(s):  
Zhanguo Li ◽  
Fengchun Zhang ◽  
Jonathan Kay ◽  
Kaiyin Fei ◽  
Chenglong Han ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document